Saffron Walden, United Kingdom

Richard J Bull

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard J Bull. Retrieved from https://idiyas.com/inventor/richard-j-bull

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard J Bull - Innovator in KDM5 Inhibitory Compounds

Introduction

Richard J Bull is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit KDM5 inhibitory activity. His work is crucial in the fight against various diseases, including cancer, Huntington's disease, and Alzheimer's disease.

Latest Patents

Richard J Bull holds a patent for a compound having KDM5 inhibitory activity and its pharmaceutical use. The compound is represented by a general formula and is useful as a prophylactic and/or therapeutic agent for several serious health conditions. This innovation highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Richard J Bull is associated with Ono Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

He has collaborated with notable colleagues, including Akito Kakuuchi and Shuhei Umemura, to further enhance the impact of his research. These partnerships reflect the collaborative nature of scientific innovation and the importance of teamwork in achieving significant breakthroughs.

Conclusion

Richard J Bull's contributions to the field of pharmaceuticals, particularly through his patent on KDM5 inhibitors, demonstrate his dedication to addressing critical health challenges. His work continues to inspire advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…